Binding of hepatitis c virus-like particles derived from infectious clone h77c to defined human cell lines

Journal of Virology

Volumn 76, Issue 3, 2002, Pages 1181-1193

  Wellnitz, Sabine ^a   Klumpp, Bettina ^a   Barth, Heidi ^a   Ito, Susumu ^a   Depla, Erik ^a   Dubuisson, Jean ^a   Blum, Hubert E ^a   Baumert, Thomas F ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN E; GLYCOPROTEIN E2; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

ARTICLE; BINDING AFFINITY; CELL CULTURE; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; VIRUS ADSORPTION; VIRUS CELL INTERACTION; VIRUS CULTURE; VIRUS REPLICATION; VIRUS VIRULENCE;

EID: 0036145390     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.3.1181-1193.2002     Document Type: Article

References (56)

1. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor
2. Hepatitis C virus envelope protein E2 binds to CD81 of tamarins
3. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis
4. The prevalence of hepatitis C virus infection in the United States 1988-1994
5. Replication of hepatitis C virus
6. The hepatitis C virus structural proteins assemble into virus-like particles in insect cells
7. Naturally occurring mutations define a novel function of the hepatitis B virus core promotor in core protein expression
8. Two core promotor mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication
9. Hepatitis C virus-like particles synthesized in insect cells as a potential vaccine candidate
10. Antibodies against hepatitis C virus-like particles and viral clearance in acute and chronic hepatitis C
11. Efficient initiation of HCV RNA replication in cell culture
12. Enzyme activation by antibodies: A method to determine the binding constant of the activating antibody towards one determinant of E. coli beta-D-galactosidase
13. Hepatitis C virus glycoprotein E2 binding to CD81: The role of E1E2 cleavage and protein glycosylation in bioactivity
14. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome
15. Isolation and characterization of human monoclonal antibodies against hepatitis C virus envelope glycoproteins
16. Formation of native hepatitis C virus glycoprotein complexes
17. Folding, assembly and subcellular localization of HCV glycoproteins
18. Identification of the alpha 6 integrin as a candidate receptor for papillomaviruses
19. Lack of protective immunity against reinfection with hepatitis C virus
20. Functional characterization of intracellular and secreted forms of a truncated hepatitis C virus E2 glycoprotein
21. Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81
22. The role of the hepatitis C virus glycoproteins in infection
23. Cleavage of rhesus rotavirus VP4 after arginine 247 is essential for rotavirus-like particle-induced fusion from without
24. Virus-like particle-induced fusion from without in tissue culture cells: Role of outer-layer proteins VP4 and VP7
25. Human papillomavirus infection requires cell surface heparan sulfate
26. Expression and identification of hepatitis C virus polyprotein cleavage products
27. Evaluation of hepatitis C virus glycoprotein E2 for vaccine design: An endoplasmic reticulum-retained recombinant protein is superior to secreted recombinant protein and DNA-based vaccine candidates
28. Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2
29. Human papillomavirus type 16 minor capsid protein L2 N-terminal region containing a common neutralization epitope binds to the cell surface and enters the cytoplasm
30. Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA
31. Hepatitis C virus-like particles induce virus-specific humoral and cellular immune responses in mice
32. Vaccines to prevent viral hepatitis
33. CD81 (TAPA-1): A molecule involved in signal transduction and cell adhesion in the immune system
34. Combination therapy for hepatitis C virus infection
35. Pathogenesis, natural history, treatment, and prevention of hepatitis C
36. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line
37. The molecular virology of hepatitis C
38. Expression of the alpha 6 integrin confers papillomavirus binding upon receptor-negative B-cells
39. Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection
40. Construction and characterization of chimeric hepatitis C virus E2 glycoproteins: Analysis of regions critical for glycoprotein aggregation and CD81 binding
41. Structure-function analysis of hepatitis C virus envelope-CD81 binding
42. Binding of hepatitis C virus to CD81
43. Epithelial cells display separate receptors for papillomavirus VLPs and for soluble L1 capsid protein
44. Flaviviridae: The viruses and their replication
45. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: Cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells
46. Interaction of recombinant Norwalk virus particles with the 105-kilodalton cellular binding protein, a candidate receptor molecule for virus attachment
47. Clinical outcomes after transfusion-associated hepatitis C
48. Use of conventional or replicating nucleic acid-based vaccines and recombinant Semliki forest virus-derived particles for the induction of immune responses against hepatitis C virus core and E2 antigens
49. Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co-stimulatory signal for human T cells
50. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: Potential role in chronic HCV infections
51. Attachment and entry of recombinant Norwalk virus capsids to cultured human and animal cell lines
52. Determination of triglycerides in lipoproteins separated by agarose gel electrophoresis
53. Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor
54. Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee
55. Neutralization of human papillomavirus (HPV) pseudovirions: A novel and efficient approach to detect and characterize HPV neutralizing antibodies
56. Antibodies in human sera specific to hypervarable region 1 of hepatitis C virus can block viral attachment